Novartis (NVS) stakeholder Emasan is offering to sell around 26.5 million shares, or a 1.2% stake, in the pharmaceutical company, Bloomberg reported Tuesday.
The deal could raise around 2.7 billion Swiss francs ($3 billion), based on Tuesday's closing share price, according to the report.
Emasan is selling the stake through an accelerated placement with investors, the report said.
Novartis did not immediately reply to a request for comment from MT Newswires.
NVS shares were 0.8% higher in recent trading.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 110.09, Change: +0.87, Percent Change: +0.80
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.